Brattås, M.K.; Hemsing, A.L.; Rye, K.P.; Hatfield, K.J.; Reikvam, H.
Heterogeneity of Patient-Derived Acute Myeloid Leukemia Cells Subjected to SYK In Vitro Inhibition. Int. J. Mol. Sci. 2022, 23, 14706.
https://doi.org/10.3390/ijms232314706
AMA Style
Brattås MK, Hemsing AL, Rye KP, Hatfield KJ, Reikvam H.
Heterogeneity of Patient-Derived Acute Myeloid Leukemia Cells Subjected to SYK In Vitro Inhibition. International Journal of Molecular Sciences. 2022; 23(23):14706.
https://doi.org/10.3390/ijms232314706
Chicago/Turabian Style
Brattås, Marte Karen, Anette Lodvir Hemsing, Kristin Paulsen Rye, Kimberley Joanne Hatfield, and Håkon Reikvam.
2022. "Heterogeneity of Patient-Derived Acute Myeloid Leukemia Cells Subjected to SYK In Vitro Inhibition" International Journal of Molecular Sciences 23, no. 23: 14706.
https://doi.org/10.3390/ijms232314706
APA Style
Brattås, M. K., Hemsing, A. L., Rye, K. P., Hatfield, K. J., & Reikvam, H.
(2022). Heterogeneity of Patient-Derived Acute Myeloid Leukemia Cells Subjected to SYK In Vitro Inhibition. International Journal of Molecular Sciences, 23(23), 14706.
https://doi.org/10.3390/ijms232314706